MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Clinical trials for MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis study is testing a new drug called AB8939 for people with acute myeloid leukemia (AML) that has come back or hasn't responded to previous treatments. The main goals are to find a safe dose and see if the drug helps control the cancer. It's for patients who have already tried…
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First human trial launches for experimental blood cancer drug
Disease control Recruiting nowThis early-stage study is testing a new drug called APL-4098 in adults with advanced forms of blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Researchers want to find the safest dose and see how well the drug works when given alone or combined …
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New transplant technique aims to stop Body's attack on itself in kids with cancer
Disease control Recruiting nowThis study is testing whether removing a specific type of immune cell (called naive T cells) from a donor's stem cells before transplant can prevent chronic graft-versus-host disease in children and young adults with blood cancers. Chronic graft-versus-host disease is a serious c…
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough blood cancers: first human trial begins
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new drug called cirtuvivint for patients with advanced forms of blood cancer. The trial will test cirtuvivint by itself in patients whose cancer has returned or resisted treatment, and also test it combined with an existing …
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC